Cargando…

Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status

The role of G protein-coupled estrogen receptor 1 (GPER) signaling, including promotion of Ezrin phosphorylation (which could be activated by estrogen), has not yet been clearly identified in triple-negative breast cancer (TNBC). This study aimed to evaluate the prognostic value of GPER and Ezrin in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Shuang, Xu, Yuanyuan, Li, Jiehao, Zheng, Shuhui, Sun, Peng, Wang, Tinghuai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528410/ https://www.ncbi.nlm.nih.gov/pubmed/30999280 http://dx.doi.org/10.1530/EC-19-0164

Ejemplares similares

Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1
por: Wang, Chen, et al.
Publicado: (2018)

Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer
por: Ye, Shuang, et al.
Publicado: (2020)

17β-Estradiol Enhances Breast Cancer Cell Motility and Invasion via Extra-Nuclear Activation of Actin-Binding Protein Ezrin
por: Zheng, Shuhui, et al.
Publicado: (2011)

GPER was Associated with Hypertension in Post-Menopausal Women
por: Liu, Shichao, et al.
Publicado: (2018)

ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer
por: Wang, Xiaoyu, et al.
Publicado: (2021)

Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells
por: Rigiracciolo, Damiano Cosimo, et al.
Publicado: (2019)

Triple Negative Breast Cancer: An Analysis of the Subtypes and the Effects of Menopausal Status on Invasive Breast Cancer
por: Nishimura, Reiki, et al.
Publicado: (2022)

High GPER expression in triple-negative breast cancer is linked to pro-metastatic pathways and predicts poor patient outcomes
por: Xu, Ting, et al.
Publicado: (2022)

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2015)

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2016)

The FTO/miR‐181b‐3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer
por: Xu, Yuanyuan, et al.
Publicado: (2020)

Prognostic implications of ezrin and phosphorylated ezrin expression in non-small cell lung cancer
por: Jin, Tiefeng, et al.
Publicado: (2014)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer
por: Slik, Khadija, et al.
Publicado: (2017)

GPER Function in Breast Cancer: An Overview
por: Lappano, Rosamaria, et al.
Publicado: (2014)

27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer
por: Avena, Paola, et al.
Publicado: (2022)

NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer
por: Meng, Ran, et al.
Publicado: (2016)

The role of BRCA status on prognosis in patients with triple-negative breast cancer
por: Xie, Yuxin, et al.
Publicado: (2017)

The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data
por: Li, Hongtao, et al.
Publicado: (2013)

GPER deletion triggers inhibitory effects in triple negative breast cancer (TNBC) cells through the JNK/c-Jun/p53/Noxa transduction pathway
por: Cirillo, Francesca, et al.
Publicado: (2023)

Expression of ezrin protein and phosphorylated ezrin in pelvic endometriotic lesions
por: Peloggia, Alessandra, et al.
Publicado: (2022)

A novel role for ezrin in breast cancer angio/lymphangiogenesis
por: Ghaffari, Abdi, et al.
Publicado: (2014)

Overweight as a Prognostic Factor for Triple-Negative Breast Cancers in Chinese Women
por: Hao, Shuang, et al.
Publicado: (2015)

Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway
por: He, Yueshuang, et al.
Publicado: (2023)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Prognostic values of EDNRB in triple-negative breast cancer
por: Liu, Shaoqing, et al.
Publicado: (2020)

Association between GPER gene polymorphisms and GPER expression levels with cancer predisposition and progression
por: Ulhaq, Zulvikar Syambani, et al.
Publicado: (2021)

Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer
por: Wang, Jianguo, et al.
Publicado: (2022)

Ezrin is required for adhesion and migration in invasive breast cancer
por: Szeto, Alvin, et al.
Publicado: (2013)

Erratum to: “A novel role for ezrin in breast cancer angio/lymphangiogenesis”
por: Ghaffari, Abdi, et al.
Publicado: (2015)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Editorial: GPER and Human Pathologies
por: Jacquot, Yves, et al.
Publicado: (2021)

Editorial: GPER: Control and Functions
por: Jacquot, Yves, et al.
Publicado: (2021)

Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects
por: Huang, Dan, et al.
Publicado: (2021)

Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonist
por: Ding, Qingming, et al.
Publicado: (2022)

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
por: Rhee, Jiyoung, et al.
Publicado: (2008)

Prognostic Value of Ezrin in Solid Tumors: A Meta-Analysis of the Literature
por: Han, Kun, et al.
Publicado: (2013)

Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance
por: Maccio, Umberto, et al.
Publicado: (2022)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rvj8qdog1p0pf49ggn0omd030o